Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"

clinical trial

Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100" is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT01677195

P6099clinical trial phasephase II clinical trialQ42824440
P17countryUnited States of AmericaQ30
P582end time2014-08-01
P4135maximum age85
P2899minimum age18
P1132number of participants234
P4844research interventioncalcium carbonateQ23767
calcium oxalateQ412399
P1813short nameRDMEACCS100
P580start time2012-09-01
P8363study typeinterventional studyQ78089383
P1476title"Phase II, Reduction of Dietary Mycotoxin Exposure in Persons in Bexar County, Texas by Ingestion of ACCS100 Capsules Compared to Placebo."

Search more.